| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |